ABSTRACT

NIAID Research Agenda for Category B and C Pathogens: Progress Report   [open pdf - 1MB]

"In response to the new sense of urgency to understand anthrax and other potential bioterrorist threats, in early 2002, NIH's National Institute of Allergy and Infectious Diseases (NIAID) developed the NIAID Strategic Plan for Biodefense Research. The purpose of the strategic plan is to guide the implementation of basic and translational biodefense research and to engage partners in academia, industry, and other private and public-sector entities to develop biodefense-related diagnostics, therapeutics, and vaccines... Significant progress also has been made since the January 2003 release of the NIAID Biodefense Research Agenda for Category B and C Priority Pathogens; these scientific advances and programmatic activities are described in this new progress report. Specific topics include: progress made towards meeting general recommendations in the areas of research, product development, and research resources, which are crucial for building a robust biodefense infrastructure; and scientific advances and research activities related to the immediate goals in the research agenda. In keeping with these goals, this progress report focuses on basic and applied research aimed at developing pathogen-specific diagnostics, therapeutics, and vaccines, as well as progress in understanding the biology of Category B and C microbes and the host response to them. The report also summarizes scientific progress in the area of immune-based strategies for biodefense."

Publisher:
Date:
2004-06
Copyright:
Public Domain
Retrieved From:
National Institute of Allergy and Infectious Diseases : http://www.niaid.nih.gov/publications/
Format:
pdf
Media Type:
application/pdf
URL:
Help with citations